Home » Newsletters » BioWorld

BioWorld

Sep. 29, 1997

View Archived Issues

Arris Calls Phase II Stumble Of Asthma Drug Minor Setback

Texas Biotechnology Raises $25M In 5M-Share Offering

AHP Pays Immunex $100M To Market Arthritis Drug In US

House Version Of FDA Reform Unanimously Clears Committee

BioCryst's Topical Treatment For Psoriasis Fails In Phase III

Other News To Note

Herpesvirus Could Yield Drugs For HIV, Inflammatory Disorders

Millennium, Lilly Extend Pact On Atherosclerosis Research